ALC — ALCON INC

NYSE · Unknown · Unknown · CIK 1167379 ·
Last close
$66.12
Market Cap
$32.25B
52W High
$81.96
52W Low
$61.83
ADV30
2,146,734
Next earnings
2026-05-05
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 2,706,000,000 1,525,000,000 292,000,000 189,000,000 31,619,000,000 1,578,000,000 9,486,000,000
Dec 2025 2,718,000,000 1,516,000,000 313,000,000 217,000,000 31,555,000,000 31,555,000,000
Sep 2025 2,614,000,000 1,458,000,000 332,000,000 237,000,000 31,524,000,000 1,498,000,000 9,436,000,000
Jun 2025 2,596,000,000 1,388,000,000 247,000,000 176,000,000 31,387,000,000 1,408,000,000 9,257,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$2,305,000,000
Investing CF
$-984,000,000
Financing CF
$-1,156,000,000
CapEx
$-714,000,000
Dividends Paid
$0
Buybacks
$-751,000,000
EPS Diluted TTM
$1.66
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
Inventory
$2,438,000,000
Receivables
$2,010,000,000
ST Investments
$81,000,000
EBIT TTM
$1,193,000,000
Pretax Income TTM
$986,000,000
Interest Exp TTM
$207,000,000
Analysts
16

Yahoo Snapshot (yfinance, live)

Total Revenue
$10,634,000,384
EBITDA
$2,312,999,936
Free Cash Flow
$1,225,500,032
Enterprise Value
$35,850,723,328
Total Cash
$1,659,000,064
Total Debt
$5,262,000,128
Shares Out
487,700,000
Trailing EPS
$1.67
Book Value
$45.38
ROE
3.7%
ROA
2.5%
Div Yield
0.54%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 10,401,000,000 1,360,000,000 980,000,000 31,555,000,000 31,555,000,000 2,271,000,000
Dec 2024 9,911,000,000 1,413,000,000 1,018,000,000 30,347,000,000 30,347,000,000 2,077,000,000
Dec 2023 9,455,000,000 1,039,000,000 974,000,000 29,614,000,000 8,990,000,000 1,388,000,000
Dec 2022 8,717,000,000 672,000,000 335,000,000 29,165,000,000 9,488,000,000 1,217,000,000
Dec 2021

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$3.97

News headlines (Yahoo Finance, 1h cache)

Alcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada
2026-06-15 13:43 · Yahoo
Reasons to Add Tandem Diabetes Stock to Your Portfolio Right Now
2026-06-04 15:56 · Yahoo
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
2026-05-28 14:02 · Yahoo
Evaluating Alcon (SWX:ALC) After Recent Share Price Weakness And Perceived Valuation Gap
2026-05-26 04:30 · Yahoo
Does Alcon (SWX:ALC) Offer Opportunity After A 26% One Year Share Price Slide?
2026-05-25 13:15 · Yahoo
Reasons to Retain STE Stock in Your Portfolio for Now
2026-05-22 16:15 · Yahoo
STAAR Surgical signals standalone strength as Alcon overhang fades after strong Q1
2026-05-20 19:33 · Yahoo
EYE Q1 Earnings & Revenues Beat Estimates, Operating Margin Expands
2026-05-15 18:17 · Yahoo
Alcon Inc. (ALC) Sees Mixed Signals After Q1 Beat and Target Reduction
2026-05-15 11:50 · Yahoo
PBH Q4 Earnings & Revenues Miss Estimates, Margins Down
2026-05-14 17:08 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.